Coherus Oncology Inc. (chrs 1.5 04/15/26)
13F holders, Q1 2025 (March 31)1holders −1
0new positions
1sold out
$0.97avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Coherus Oncology Inc. (chrs 1.5 04/15/26) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holder was Avantax Advisory Services, Inc. ($10K).
- Company
- Coherus Oncology Inc. (chrs 1.5 04/15/26)
- CUSIP
- 19249HAB9
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2.9M |
All 13F filers, Q4 2024 → Q1 2025: 3,000,000 shares sold, net −3,000,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Avantax Advisory Services, Inc. | 0.00% | No change | 10,000 | $10K |
"% of holder's portfolio" is COHERUS ONCOLOGY INC (CHRS 1.5 04/15/26)'s weight in each manager's 13F, not the share of Coherus Oncology Inc. (chrs 1.5 04/15/26) the manager owns.